• Bronchial carcinoma: Added benefit of crizotinib not proven

    9 monthes ago - By Science Daily

    The dossier contains no data or no suitable data on ROS1-positive, advanced non-small cell lung cancer. Results on ALK-positive tumors are not applicable.
    Read more ...